Masimo's fourth-quarter 2024 results continue to benefit from the strength in its Healthcare and Non-healthcare businesses.
Vous n'êtes pas connecté
TFX benefits from a diversified product portfolio in the fourth quarter of 2024, with strength in the Surgical and Interventional segments.
Masimo's fourth-quarter 2024 results continue to benefit from the strength in its Healthcare and Non-healthcare businesses.
Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the fourth quarter of...
TMDX's fourth-quarter earnings depict strength in the company's net product revenues and services revenues. A rise in operating income bodes well for...
KBR's fourth-quarter 2024 results reflect strong contributions from its GS and STS segments and benefits from the LinQuest acquisition.
The strength in OPKO Health's transfer of intellectual property and other revenues boosts its overall fourth-quarter 2024 performance despite lower...
VITL's fourth-quarter results reflect higher sales and earnings. Also, the adjusted EBITDA margin increases 130 basis points to 11.5% in the quarter.
BBWI's fourth-quarter results reflect lower y/y revenues and higher earnings. The operating margin increases 40 basis points to 24.3% in the quarter.
Teleflex (TFX) delivered earnings and revenue surprises of 0.78% and 2.23%, respectively, for the quarter ended December 2024. Do the numbers hold...
Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended December 2024, it might be worth...
Hims & Hers' revenue channels witness strong growth on the back of solid product demand in the fourth quarter.